Latest Videos |view all videos
Video
New CAR T Clinical Trials Underway at Roswell Park for Solid Tumor, Non-cancerous Diseases
While the focus and promise of CAR T-cell therapies has long been on liquid tumors and hematologic malignancies, new trials under way at Roswell Park Comprehensive Cancer Center are expanding the applications of immunotherapy to include other diseases.
Video
Discover how Roswell Park Comprehensive Cancer Center is transforming GI cancer care with cutting-edge advancements in minimally invasive robotic surgery, innovative hepatic artery pump therapy, and multidisciplinary treatment for recurrent rectal cancer.
Video
Meet the Team: Cerrene Giordano, MD
Cerrene Giordano, MD, believes the future of dermatology involves embracing what artificial intelligence can do to help treat patients with skin cancer.
Video
Advances in Ovarian Cancer Treatment Show Promise for Longer Response, Survival Rates
While it remains the leading cause of death among patients with gynecologic cancers, new treatments are offering patients better outcomes and better quality of life.
Video
Graft Versus Host Disease No Longer Poses High Risk to Transplant Patients
Graft versus host disease (GVHD) used to present such a risk to transplant patients, an estimate 10-15% of patients would develop a fatal case of it.
Video
Meet the Team: Nicole Gaulin, MD
For Nicole Gaulin, MD, the newest member of the gynecologic oncology team at Roswell Park Comprehensive Cancer Center, the ability to treat patients throughout their disease played an important role in choosing her career path.
Video
New Clinical Trials for Cervical Cancer Now Available at Roswell Park
Groundbreaking new treatments, including a handful of clinical trials, are now available for patients at Roswell Park Comprehensive Cancer Center, says gynecologic oncologist Karen McLean, MD, PhD, FCAOG.
Video
Immunotherapies, Antibody Drug Conjugants Among Advances in Endometrial Cancer Treatment Options
While the majority of endometrial cancer cases are diagnosed early and patients have an excellent prognosis, those diagnosed with advanced or recurrent endometrial cancer often face a worse prognosis and their treatment can be more difficult.
BROADCASTMED